Skip to main content
Enter your The Contraceptive Pipeline Database username.
Enter the password that accompanies your username.
MENT Transdermal Gel
MENT is a synthetic androgen that resembles testosterone. MENT binds to androgen receptors with greater binding affinity than testosterone and dihydrotestosterone, the two active endogenous androgens. The higher binding affinity results in higher bioactivity so that the total dose can be reduced compared to the dose of testosterone required for daily use.
May 30, 2018
Active Pharmaceutical Ingredient (API):
Ethanol and other absorption enhancers
Potential Multi-Purpose Technology (MPT):
Began discovery in:
Early studies indicated that MENT gel suppressed steroid sex hormones over a seven-day treatment period, and that the effect was reversible when treatment ended.
MENT was licensed to Schering AG, Germany for replacement therapy in 2001. After the acquisition by Bayer, the company decided to close the program.
See also entry on MENT Implant.
Download Product Report